Roblox Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Roblox Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $2.23B | Feb 28, 2023 |
| FY2022 | Dec 31, 2021 | $1.92B | Feb 28, 2023 |
| FY2022 | Dec 31, 2020 | $923.89M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $508.39M | Feb 25, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.89B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.60B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $2.80B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $2.23B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.92B | Feb 21, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.07B) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | ($935.38M) | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | ($1.15B) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | ($924.37M) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | ($491.65M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | ($253.25M) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($70.97M) | Feb 25, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.23B) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | ($1.06B) | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | ($1.26B) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | ($923.78M) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | ($495.10M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | ($266.14M) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($76.44M) | Feb 25, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.57B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.44B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.25B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $873.48M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $533.21M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $201.43M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $107.10M | Feb 25, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.80B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $822.32M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $458.18M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $369.30M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $659.11M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $524.34M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $99.19M | Feb 25, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $440.98M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $179.65M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $320.67M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $426.16M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $93.27M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $104.15M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $83.26M | Feb 25, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.56B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $7.18B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $6.17B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $5.38B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $4.56B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.85B | Feb 25, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.18B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $6.97B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $6.10B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $5.07B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $3.97B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.74B | Feb 25, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $394.48M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $221.45M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $76.29M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $306.03M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $584.82M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | ($252.39M) | Feb 25, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $142.62M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $141.69M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $142.13M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $134.34M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $118.07M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $59.57M | Feb 28, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.06B) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | ($4.00B) | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | ($3.06B) | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | ($1.91B) | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | ($983.94M) | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | ($492.29M) | Feb 25, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.21B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $711.68M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $678.47M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $2.98B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $3.00B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $893.94M | Feb 25, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | Feb 11, 2026 |
| FY2024 | Dec 31, 2024 | $1.21B | Feb 18, 2025 |
| FY2023 | Dec 31, 2023 | $1.25B | Feb 21, 2024 |
| FY2022 | Dec 31, 2022 | $1.29B | Feb 28, 2023 |
| FY2021 | Dec 31, 2021 | $1.33B | Feb 25, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 25, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 25, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 708.36M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 666.42M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 631.22M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | 604.67M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 585.88M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 201.33M | Feb 25, 2022 |